ACORN CAPITAL ADVISORS, LLC

CIK 0002054410 · NEW YORK, NY · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source

ACORN CAPITAL ADVISORS, LLC reported 20 positions worth $366.5M as of June 30, 2026 (13F filed August 14, 2026). Largest holding: CGON (21.9%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$366.5M
2026 Q2
Positions
20
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
90.2%
Est. Net Flow (Q)
2026 Q2
10 / 20 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1CGONCG ONCOLOGY INCSH$80.4M21.94%1,131,500
2URGNUROGEN PHARMA LTDSH$61.6M16.80%1,673,420
3TRVITREVI THERAPEUTICS INCSH$40.0M10.92%2,144,844
4CADLCANDEL THERAPEUTICS INCSH$36.0M9.83%3,497,948
5PBYIPUMA BIOTECHNOLOGY INCSH$33.5M9.14%4,131,299
6JBIOJADE BIOSCEINCES INCSH$21.9M5.98%986,760
7BCAXBICARA THERAPEUTICSSH$19.1M5.21%643,381
8KPTIKARYOPHARM THERAPEUTICS INCSH$14.8M4.05%1,518,113
9OKURONKURE THERAPEUTICS INCSH$12.9M3.53%2,839,674
10HELPHELUS PHARMA INC.SH$10.2M2.78%1,540,266

The free plan shows the top 10 positions. The remaining 10 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does ACORN CAPITAL ADVISORS, LLC hold as of Q2 2026?

ACORN CAPITAL ADVISORS, LLC reported 20 positions worth $366.5M in its Q2 2026 13F filing. Largest positions: CGON (21.9%), URGN (16.8%), TRVI (10.9%), CADL (9.8%) and PBYI (9.1%).

What did ACORN CAPITAL ADVISORS, LLC buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did ACORN CAPITAL ADVISORS, LLC sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.